Clinical Course of Pediatric Acute Respiratory Distress Syndrome at Moderate Altitude

María A Chacón1, Alejandra Calderon2, Jaime Fernández-Sarmiento3

  • 1Pediatric Critical Care, Universidad de La Sabana, Bogotá, COL.

Cureus
|November 2, 2020
PubMed

Insights

Pediatric acute respiratory distress syndrome at moderate altitudes shows similar outcomes to low altitudes. However, the Pa/Fi ratio is not a reliable predictor for mild to moderate cases.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pulmonology
  • Altitude Physiology

Background:

  • Pediatric acute respiratory distress syndrome (PARDS) epidemiology and outcomes at moderate altitudes require further characterization.
  • Understanding PARDS in diverse environments is crucial for global health equity.

Purpose of the Study:

  • To describe the epidemiology, clinical features, and outcomes of pediatric acute respiratory distress syndrome (PARDS) in patients residing at moderate altitude.
  • To evaluate the predictive value of the Pa/Fi ratio for mortality in PARDS at moderate altitude.

Main Methods:

  • Retrospective case series of 88 children diagnosed with PARDS and admitted to the Pediatric Intensive Care Unit (PICU) between March 2009 and March 2014.
  • Data collected included demographic information, mechanical ventilation parameters, gas exchange, hemodynamics, and organ dysfunction.
  • Analysis of mortality rates based on severity (mild, moderate, severe) and correlation with clinical parameters like serum lactate and positive end-expiratory pressure.

Main Results:

  • Bronchiolitis and pneumonia were the leading causes of PARDS.
  • The overall mortality rate was 19.5%.
  • Mortality varied significantly with severity: 46.7% for severe PARDS (Pa/Fi <100), 11.9% for moderate (Pa/Fi 100-200), and 25% for mild (Pa/Fi 200-300).
  • Serum lactate and positive end-expiratory pressure showed a significant relationship with mortality (p = 0.02 and p = 0.0013, respectively).

Conclusions:

  • Pediatric acute respiratory distress syndrome patients at moderate altitudes exhibit clinical behavior and mortality rates comparable to those at low altitudes.
  • The Pa/Fi ratio demonstrated limited utility in predicting mortality for patients with mild and moderate PARDS.
  • Further research may explore alternative biomarkers or predictors for PARDS severity and outcomes at altitude.

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
391
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.7K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
555
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
324
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
820
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
594